1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
FY26 Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award is sponsored by Congressionally Directed Medical Research Programs (CDMRP) - Department of Defense. This award supports the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for diseases or conditions related to the FY26 PRMRP topic areas and strategic goals.
Get alerted about grants like this
Get emailed when new opportunities from “Congressionally Directed Medical Research Programs (CDMRP) - Department of Defense” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Congressionally Directed Medical Research Programs (CDMRP) -- Peer Reviewed Medical Research Program -- Technology/Therapeutic Development Award | Research Funding Congressionally Directed Medical Research Programs (CDMRP) -- Peer Reviewed Medical Research Program -- Technology/Therapeutic Development Award The fiscal year 2026 (FY26) Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award, a product-driven award mechanism, intends to support the translation of promising preclinical findings into products for clinical applications, including prevention, detection, diagnosis, treatment, or quality of life, for a disease or condition related to one of the congressionally directed FY26 PRMRP topic areas and one of the FY26 PRMRP strategic goals.
Products can be tangible items, such as drugs or devices, or can be knowledge products, such as clinical decision-making tools or practice guidelines. Products in development should address or have dual purpose potential for the health care needs of military Service Members, Veterans and their Families.
Distinctive Features: For the PRMRP Technology/Therapeutic Development Award, the program expects the research proposed will take an already established proof-of-concept or prototype through the final stages of preclinical development. The PRMRP also expects that the research outcome will be a regulatory filing or translation of findings into clinical practice, as applicable.
• Required Pre-Application Deadline: July 23, 2026 • Application Submission Deadline: August 6, 2026 Independent investigators (e.g., Assistant Professor, Senior Scientist, Principal Scientist, Research Director, or equivalent) may be named by the organization as the Principal Investigator (PI) on the application. Each investigator may be named on only one FY26 PRMRP application as a PI.
If more than one pre-application submitted to the FY26 PRMRP names the same PI, the first submission will be accepted, and subsequent submissions will be administratively withdrawn. Independent investigators affiliated with an eligible organization are eligible to be named PI on the application, regardless of ethnicity, nationality or citizenship status.
The Congressionally Directed Medical Research Programs (CDMRP) expects to allot roughly $67. 2M to fund approximately 12 Technology/Therapeutic Development Award applications with total cost caps of $5. 6M per award.
The maximum period of performance is 4 years. It is anticipated that awards made from this FY26 funding opportunity will be funded with FY26 funds, which will expire for use on September 30, 2032. Awards supported with FY26 funds will be made no later than September 30, 2027.
Engineering and Physical Sciences Environmental & Life Sciences Medical - Clinical Science
According to the current listing, eligibility includes: Independent investigators (e. g. , Assistant Professor, Senior Scientist, Principal Scientist, Research Director, or equivalent) may be named by the organization as the Principal Investigator (PI) on the application. Confirm the full requirements in the official notice before applying.
The published deadline was August 6, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
FY26 Peer Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award is funded by Congressionally Directed Medical Research Programs (CDMRP) - Department of Defense. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
DoD Multidisciplinary Research Program of the University Research Initiative (MURI) is sponsored by Department of Defense (DoD) - Office of Naval Research (ONR). The Multidisciplinary Research Program of the University Research Initiative (MURI), administered by the Department of Defense Office of Naval Research, supports basic research in science and engineering at U. S.
SBIR SF254-D1206: Knowledge-Guided Test and Evaluation Frameworks for proliferated Low Earth Orbit Constellations is sponsored by U.S. Air Force. DOD SBIR topic SF254-D1206: Knowledge-Guided Test and Evaluation Frameworks for proliferated Low Earth Orbit Constellations. Component: U.S. Air Force. Command: SDA. Solicitation: DoD SBIR 2025.4. Phase(s): D2PII, II, SPII. Status: Pre-Release. Open date: 3/4/2026.
The Congressionally Directed Medical Research Programs just released $1.27 billion across 34 programs. Universities, nonprofits, and small businesses are all eligible.
Read articleThe Department's FY26 SBIR/STTR Release 3 opened June 24 with roughly 37 topics across DARPA, the Navy, the Air Force, and the defense components, all closing July 22. The compressed four-week window is unforgiving, but the bigger mistake founders make is treating every component the same. Here is how to read the release, the eligibility rules that disqualify good companies, and why the component you target matters more than the topic you pick.
Read articleDoW's 2026 SBIR Broad Agency Announcement now operates on a monthly pre-release / quarterly close cadence. The 42 topics closing June 24 are the first test of whether the new rhythm produces the steady-state deal flow defense innovators have been asking for since 2022.
Read article